Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

70031-70040 of 70129 results

Catalogue Number:

AMM09177V

Category:

G

VMAT2 (SLC18A2) Mouse Monoclonal Antibody [Clone ID: LBI9E11]

Target: SLC18A2
Species Reactivity: Human, Mouse, Rat
Applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry, Western Blot
Type: Primary Recombinant
Host Species: Mouse
Animal-Derived Biomaterials Used: BSA, KLH, FCS, Other
Sequence Available No
Original Discovery Methods Animal-derived from single B cell, Animal-derived from hybridomas excluding ascites
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

PX-TA1366

Category:

G

Vobarilizumab Biosimilar – Anti-ALB/ IL6R/ CD126 mAb – Research Grade

Target: ALB/ IL6R/ CD126
Target Alias Name: Vobarilizumab/(20A11-9mer-ALB11)/ALX-0061/ALB/ IL6R/ CD126 /anti-ALB/ IL6R/ CD126
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: VH-VH'
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1890

Category:

G

Vobramitamab Biosimilar – Anti-CD276 mAb – Research Grade

Target: CD276
Target Alias Name: Vobramitamab//CD276/anti-CD276
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1548

Category:

G

Vofatamab Biosimilar – Anti-FGFR3 mAb – Research Grade

Target: FGFR3
Target Alias Name: Vofatamab /MFGR1877S/FGFR3/anti-FGFR3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1556

Category:

G

Volagidemab Biosimilar – Anti-GCGR mAb – Research Grade

Target: GCGR
Target Alias Name: Volagidemab /AMG 477/REMD-477/GCGR/anti-GCGR
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1183

Category:

G

Volociximab Biosimilar – Anti-ITGA5/ CD49e mAb – Research Grade

Target: ITGA5/ CD49e
Target Alias Name: Volociximab//ITGA5/ CD49e/anti-ITGA5/ CD49e
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2077

Category:

G

Volrustomig Biosimilar – Anti-PD1 and CTLA4 mAb – Research Grade

Target: PD1 and CTLA4
Target Alias Name: anti-PD1/ Programmed cell death protein 1/ Protein PD-1/ hPD-1/ PDCD1/ CD279/ CTLA4/ CTLA-4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa/kappa-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1424

Category:

G

Vonlerolizumab Biosimilar – Anti-TNFRSF4/ CD134 mAb – Research Grade

Target: TNFRSF4/ CD134
Target Alias Name: Vonlerolizumab/MOXR-0916/MOXR0916/RG-7888/RO7021608/TNFRSF4/ CD134/anti-TNFRSF4/ CD134
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1982

Category:

G

Vonsetamig Biosimilar – Anti-Tumor necrosis factor receptor superfamily member 17 mAb – Research Grade

Target: Tumor necrosis factor receptor superfamily member 17
Target Alias Name: anti-Tumor necrosis factor receptor superfamily member 17/ TNFRSF17/ CD269/ B-cell maturation protein/ BCMA/ BCM/ T3E/ T-cell surface antigen T3/Leu-4 epsilon chain/ CD3e/ CD3E/ T-cell surface glycoprotein CD3 epsilon chain
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1937

Category:

G

Vopikitug Biosimilar – Anti-IL2-RA mAb – Research Grade

Target: IL2-RA
Target Alias Name: anti-IL2-RA/ IL-2R subunit alpha/ TAC antigen/ IL-2-RA/ p55/ IL2RA/ IL-2 receptor subunit alpha/ Interleukin-2 receptor subunit alpha/ CD25
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression